Markus Möhler

Title: Innovations by Inventor Markus Möhler

Introduction

Markus Möhler is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for tumor treatment. With a total of two patents to his name, his work focuses on innovative solutions for serious health issues.

Latest Patents

Markus Möhler's latest patents include the invention of 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment. This invention relates to pharmaceutical compositions that contain these compounds, which target protein kinases such as GSK-3beta, VEGFR-2, and FLT-3, demonstrating antineoplastic activity. These compounds are particularly useful for the treatment or prevention of solid tumors. Another significant patent involves 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives for the treatment of colon and gastric adenocarcinoma. This invention describes a compound that can be used to treat colorectal or gastric adenocarcinoma, showcasing the potential of these derivatives in cancer therapy.

Career Highlights

Markus Möhler has worked at prestigious institutions, including Johannes Gutenberg-Universität Mainz and Universitätsmedizin der Johannes Gutenberg-Universität Mainz. His academic and research endeavors have positioned him as a key figure in the development of innovative pharmaceutical solutions.

Collaborations

Throughout his career, Markus has collaborated with notable colleagues such as Gerd Dannhardt and Annett Maderer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Markus Möhler's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to addressing critical health challenges. His work continues to pave the way for advancements in cancer treatment.